Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former SNN exec to head up Rex Bionics

This article was originally published in Clinica

Executive Summary

Robotic exoskeleton developer Rex Bionics has appointed Crispin Simon CEO; when Mr Simon joins in October 2014, current chief Jeremy Curnock Cook will become the firm’s deputy chair. Rex’s new leader has 25 years’ industry experience, having worked for NM Rothschild, McKinsey, Rexam and Smith & Nephew, where he was latterly president of S&N’s endoscopy division. Most recently, Mr Simon was CEO of UK bead technology specialist Biocompatibles, which was acquired by BTG in November 2010. Since 2012, he has been a director in the UK Government's Department of Business, Innovation and Skills.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT101818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel